Ardelyx reported $4.99M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbott ABT:US USD 10.09B 319M
Amgen AMGN:US USD 6.65B 58M
Ardelyx ARDX:US USD 4.99M 2.46M
Astrazeneca AZN:US USD 10.98B 211M
Biocept BIOC:US USD 5.59M 5.02M
Chimerix CMRX:US USD 32.56M 32.12M
Corcept Therapeutics CORT:US USD 101.73M 1.66M
Curis CRIS:US USD 2.82M 432K
Opko Health OPK:US USD 179.74M 130.15M
Tg Therapeutics TGTX:US USD 94K 500K
United Therapeutics UTHR:US USD 516M 49.1M
Xoma XOMA:US USD 451K 532K